Grants Awarded in 2012
M1 Versus M2 Polarization of the Hemophagocyte: Insight into Biologic FunctionEdward Behrens MD
The Children's Hospital of Philadelphia - Philadelphia, Pennsylvania, USA
Improving Diagnostics of and Gaining Mechanistic Insights into Defects in Lymphocyte Cytotoxicity Underlying HLHYenan Bryceson PhD
Karolinska Institutet Center for Infectious Medicine - Stockholm, Sweden
Analysis of Jagged2 Signaling in Langerhans Cell HistiocytosisCaroline Hutter MD, PhD
Children's Cancer Research Institute/St. Anna Kinderspital - Vienna, Austria
Focused Screening of Novel Therapies for HLH Using an Animal ModelMichael Jordan MD
Cincinnati Children's Hospital Medical Center - Cincinnati, Ohio USA
Research Infrastructure for Clinical and Translational Research in Langerhans Cell Histiocytosis (LCH)Carlos Rodriguez-Galindo MD
Dana-Farber Cancer Institute - Boston, Massachusetts USA
Whole Exome Sequencing of Langerhans Cell HistiocytosisBarrett Rollins MD, PhD; Astrid G.S. van Halteren PhD
Dana-Farber Cancer Institute - Boston, Massachusetts USA
Leiden University Medical Center - Leiden, The Netherlands
Histiocyte Society Clinical Trials Database System LCH-IV Treatment Protocol StudyHistiocyte Society Executive Board
LCH Study Reference Center - Vienna, Austria
Return to Grant Awards page